The dark side of immunotherapy: pancreatic cancer

Since the journal Science deemed cancer immunotherapy as the “breakthrough of the year” in 2014, there has been an explosion of clinical trials involving immunotherapeutic approaches that, in the last decade - thanks also to the renaissance of the immunosurveillance theory (renamed the three Es theo...

Descripción completa

Detalles Bibliográficos
Autores principales: Mucciolo, Gianluca, Roux, Cecilia, Scagliotti, Alessandro, Brugiapaglia, Silvia, Novelli, Francesco, Cappello, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992483/
https://www.ncbi.nlm.nih.gov/pubmed/35582441
http://dx.doi.org/10.20517/cdr.2020.13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992483/
https://www.ncbi.nlm.nih.gov/pubmed/35582441
http://dx.doi.org/10.20517/cdr.2020.13

Ejemplares similares